Guardian Pharmacy Files DEFA14A: Shareholder Vote Imminent

Ticker: GRDN · Form: DEFA14A · Filed: Mar 26, 2026 · CIK: 0001802255

Complexity: simple

Sentiment: neutral

Topics: proxy-materials, shareholder-vote, corporate-governance

TL;DR

**Guardian Pharmacy just filed a DEFA14A, signaling a key shareholder vote is on the horizon.**

AI Summary

Guardian Pharmacy Services, Inc. filed a DEFA14A on March 26, 2026, which is additional definitive proxy soliciting materials. This filing indicates the company is likely preparing for an upcoming shareholder vote or seeking shareholder approval for a specific corporate action. For investors, this matters because it signals potential changes in company governance, strategy, or ownership, which could impact the stock's future performance and valuation.

Why It Matters

This filing suggests Guardian Pharmacy Services, Inc. is actively engaging shareholders for an important decision, which could influence the company's strategic direction and future value.

Risk Assessment

Risk Level: medium — The DEFA14A itself doesn't detail the specific proposal, introducing uncertainty about the nature and potential impact of the upcoming shareholder vote.

Analyst Insight

An investor should monitor subsequent filings (like DEF 14A or PRE 14A) from Guardian Pharmacy Services, Inc. to understand the specific proposals being put to a shareholder vote, as this will clarify the potential impact on the company and its stock.

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this document?

This document is a DEFA14A, which stands for Additional definitive proxy soliciting materials and Rule 14(a)(12) material, filed by Guardian Pharmacy Services, Inc. on March 26, 2026.

Who is the filer of this DEFA14A document?

The filer of this DEFA14A document is Guardian Pharmacy Services, Inc., with CIK 0001802255 and EIN 200100834.

When was this DEFA14A filing submitted and accepted by the SEC?

This DEFA14A filing was submitted on March 26, 2026, and accepted on March 26, 2026, at 07:20:13.

What is the business address of Guardian Pharmacy Services, Inc. as stated in the filing?

The business address of Guardian Pharmacy Services, Inc. is 300 GALLERIA PARKWAY SE SUITE 800 ATLANTA GA 30339, and their phone number is (404) 810-0089.

What is the SIC code and industry classification for Guardian Pharmacy Services, Inc.?

Guardian Pharmacy Services, Inc. has an SIC code of 5912, which corresponds to Retail-Drug Stores and Proprietary Stores, and is classified under CF Office: 07 Trade & Services.

Filing Stats: 596 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2026-03-26 07:20:13

Filing Documents

From the Filing

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Guardian Pharmacy Services, Inc. (Name of Registrant as Specified in Its Charter) N/A (Name of Person(s) Filing Proxy Statement if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. P.O. BOX 8016, CARY, NC 27512-9903 Guardian Pharmacy Services, Inc. Annual Meeting of Stockholders Tuesday, May 5, 2026 1:00 PM, Eastern Time 8909 Purdue Road, Suite 500, Indianapolis, IN 46268 For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/GRDN To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the Internet. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before April 24, 2026. Meeting Materials: Notice of Meeting and Proxy Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting To Be Held On May 5, 2026 For Stockholders of record as of March 13, 2026 To order paper materials, use one of the following methods. Internet: www.investorelections.com/GRDN Call: 1-866-648-8133 Email: paper@investorelections.com * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Have the 12 digit control number located in the box above available when you access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA Copyright © 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved Guardian Pharmacy Services, Inc. Annual Meeting of Stockholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR each of the nominees listed in PROPOSAL 1, FOR PROPOSALS 2 and 4 and for 1 YEAR on PROPOSAL 3. PROPOSAL 1. To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified. 1.01 John Ackerman 1.02 Randall Lewis 2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. 3. To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. 4. To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026.

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing